COMPANY
TECLens
Funding and NIH signals
- SEC Form D raise Raised $5.23M in debt securities (Form D filed Jul 24, 2026). SEC Form D 0001708436-26-000003 (Jul 24, 2026)
Evidence (1 event)
- Jul 24, 2026 · SEC Form D 0001708436-26-000003
Name of Issuer: TECLens, Inc.; CIK: 1708436; Address: Stamford, CT; Submission type: D; Filing date: 2026-07-24; Industry Group: Other Health Care; Date of First Sale: 2026-07-09; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10230000; Total Amount Sold: 5230000; Federal exemptions: 06b
- Jul 24, 2026 · SEC Form D 0001708436-26-000003
Timeline
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07208604 | Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. | I | Not yet recruiting | Sep 30, 2025 | 2026-08 (estimated) |
| NCT07137767 | Quantitative Refractive Crosslinking in Presbyopia Aged Patients | Not phased (device or behavioral study) | Not yet recruiting | Aug 31, 2025 | 2026-08 (estimated) |